SRL and neoplasm: High tumor HBV-SRL expression level was associated with higher rates of recurrence and poor prognosis after hepatectomy in HBV-related HCC, suggesting that HBV-SRL may serve as a new diagnostic marker for tumor recurrence and a potential target for HBV-related oncogenes inhibition.